Regulatory News:
Under the liquidity contract entered into by ABIONYX Pharma (Paris:ABNX) with TP ICAP (Europe) SA, the following assets were included in the liquidity account at June 30, 2025:
- Number of shares: 162,298
- Cash balance: 86,279.52
During the 1st half of 2025, a total of
PURCHASE | 223,631 shares | 275,707.78 | 253 transactions |
SALE | 214,077 shares | 272,643.70 | 226 transactions |
As a reminder, at the half-yearly balance sheet date of December 31, 2024, the following assets were included in the liquidity account:
- Number of shares: 152,744 shares
- Cash balance: 90,498.64
When the liquidity contract was set up, the following resources were made available:
- Number of shares: 131,000 shares
- Cash balance: 40,801.20
ANNEX H1 2025
Purchases | Sales | |||||
ABNX FP | number of
| Number of
| Capital in
| number of
| Number of
| Capital in EUR |
Total | 253 | 223,631 | 275,707.78 | 226 | 214,077 | 272 ,643.696 |
20250101 | 0 | 0 | 0,00 | 0 | 0 | 0,00 |
20250102 | 1 | 1 | 1,20 | 1 | 1 | 1,20 |
20250103 | 4 | 4 731 | 5 598,24 | 1 | 1 | 1,20 |
20250106 | 2 | 2 151 | 2 555,39 | 1 | 1 | 1,19 |
20250107 | 2 | 2 091 | 2 475,76 | 2 | 2 | 2,41 |
20250108 | 1 | 1 | 1,21 | 6 | 16 781 | 20 838,45 |
20250109 | 1 | 1 | 1,28 | 3 | 4 091 | 5 261,22 |
20250110 | 5 | 6 674 | 8 375,50 | 1 | 1 | 1,30 |
20250113 | 2 | 2 321 | 2 915,20 | 1 | 1 | 1,28 |
20250114 | 2 | 2 251 | 2 827,26 | 1 | 1 | 1,26 |
20250115 | 3 | 2 283 | 2 834,77 | 2 | 1 364 | 1 732,25 |
20250116 | 2 | 2 181 | 2 708,83 | 2 | 54 | 68,58 |
20250117 | 1 | 1 | 1,27 | 5 | 12 861 | 16 681,79 |
20250120 | 2 | 2 411 | 3 134,32 | 3 | 4 051 | 5 396,12 |
20250121 | 4 | 5 141 | 6 583,61 | 1 | 1 | 1,29 |
20250122 | 2 | 2 391 | 3 003,11 | 1 | 1 | 1,27 |
20250123 | 2 | 2 321 | 2 910,53 | 2 | 98 | 125,61 |
20250124 | 2 | 2 251 | 2 827,28 | 2 | 3 | 3,85 |
20250127 | 3 | 3 001 | 3 731,25 | 1 | 1 | 1,25 |
20250128 | 1 | 1 | 1,24 | 1 | 1 | 1,24 |
20250129 | 4 | 3 726 | 4 523,13 | 1 | 1 | 1,24 |
20250130 | 2 | 300 | 362,40 | 1 | 1 | 1,21 |
20250131 | 2 | 16 | 19,30 | 4 | 8 891 | 11 103,15 |
20250203 | 3 | 3 141 | 3 830,03 | 2 | 72 | 90,00 |
20250204 | 2 | 2 251 | 2 710,21 | 1 | 1 | 1,21 |
20250205 | 1 | 1 | 1,22 | 2 | 2 | 2,44 |
20250206 | 2 | 2 181 | 2 630,31 | 1 | 1 | 1,23 |
20250207 | 2 | 2 131 | 2 544,42 | 1 | 1 | 1,20 |
20250210 | 1 | 1 | 1,22 | 2 | 2 | 2,44 |
20250211 | 1 | 1 | 1,20 | 1 | 1 | 1,20 |
20250212 | 1 | 1 | 1,20 | 4 | 6 289 | 7 736,41 |
20250213 | 3 | 3 011 | 3 659,43 | 2 | 2 | 2,49 |
20250214 | 1 | 1 | 1,23 | 2 | 2 | 2,46 |
20250217 | 2 | 250 | 300,50 | 3 | 4 441 | 5 480,40 |
20250218 | 1 | 1 | 1,24 | 4 | 4 329 | 5 463,59 |
20250219 | 3 | 3 201 | 3 941,54 | 2 | 392 | 494,68 |
20250220 | 1 | 1 | 1,33 | 6 | 15 961 | 21 228,13 |
20250221 | 1 | 1 | 1,31 | 2 | 738 | 972,68 |
20250224 | 3 | 3 621 | 4 697,72 | 1 | 1 | 1,32 |
20250225 | 1 | 1 | 1,33 | 5 | 11 351 | 15 354,69 |
20250226 | 3 | 3 811 | 5 134,77 | 3 | 3 591 | 4 962,95 |
20250227 | 3 | 3 821 | 5 140,51 | 1 | 1 | 1,35 |
20250228 | 4 | 5 691 | 7 466,21 | 1 | 1 | 1,35 |
20250303 | 1 | 1 | 1,30 | 6 | 12 891 | 17 168,66 |
20250304 | 4 | 6 181 | 8 071,89 | 2 | 2 | 2,69 |
20250305 | 2 | 2 | 2,54 | 2 | 1 559 | 2 023,55 |
20250306 | 2 | 2 921 | 3 727,21 | 1 | 1 | 1,29 |
20250307 | 3 | 3 871 | 4 913,61 | 1 | 1 | 1,27 |
20250310 | 3 | 3 721 | 4 715,77 | 1 | 1 | 1,27 |
20250311 | 4 | 5 571 | 6 855,74 | 1 | 1 | 1,26 |
20250312 | 1 | 1 | 1,24 | 1 | 1 | 1,24 |
20250313 | 2 | 424 | 517,30 | 3 | 4 051 | 5 072,04 |
20250314 | 3 | 3 571 | 4 439,97 | 1 | 1 | 1,25 |
20250317 | 2 | 2 561 | 3 129,56 | 1 | 1 | 1,24 |
20250318 | 1 | 1 | 1,24 | 1 | 1 | 1,24 |
20250319 | 2 | 2 481 | 3 031,78 | 1 | 1 | 1,22 |
20250320 | 2 | 2 411 | 2 941,43 | 3 | 4 231 | 5 297,39 |
20250321 | 1 | 1 | 1,26 | 7 | 19 891 | 25 919,78 |
20250324 | 3 | 3 627 | 4 672,00 | 2 | 972 | 1 281,10 |
20250325 | 2 | 2 901 | 3 690,09 | 1 | 1 | 1,29 |
20250326 | 1 | 1 | 1,29 | 1 | 1 | 1,29 |
20250327 | 1 | 1 | 1,28 | 1 | 1 | 1,28 |
20250328 | 1 | 1 | 1,28 | 1 | 1 | 1,28 |
20250331 | 2 | 1 862 | 2 346,13 | 1 | 1 | 1,27 |
20250401 | 5 | 9 031 | 11 067,11 | 1 | 1 | 1,27 |
20250402 | 4 | 5 341 | 6 540,66 | 1 | 1 | 1,24 |
20250403 | 3 | 3 301 | 4 051,43 | 1 | 1 | 1,23 |
20250404 | 5 | 7 581 | 9 022,58 | 1 | 1 | 1,24 |
20250407 | 7 | 10 871 | 12 406,55 | 1 | 1 | 1,19 |
20250408 | 2 | 1 338 | 1 493,23 | 5 | 9 741 | 11 244,94 |
20250409 | 4 | 4 202 | 4 770,74 | 1 | 1 | 1,14 |
20250410 | 1 | 1 | 1,18 | 5 | 13 821 | 16 335,50 |
20250411 | 2 | 2 451 | 2 857,87 | 1 | 1 | 1,17 |
20250414 | 2 | 911 | 1 060,43 | 2 | 2 | 2,38 |
20250415 | 2 | 2 351 | 2 741,29 | 1 | 1 | 1,19 |
20250416 | 2 | 640 | 744,96 | 1 | 1 | 1,16 |
20250417 | 1 | 1 | 1,19 | 2 | 2 231 | 2 659,35 |
20250418 | 0 | 0 | 0,00 | 0 | 0 | 0,00 |
20250421 | 0 | 0 | 0,00 | 0 | 0 | 0,00 |
20250422 | 1 | 1 | 1,20 | 3 | 4 481 | 5 386,40 |
20250423 | 1 | 1 | 1,19 | 3 | 4 321 | 5 280,47 |
20250424 | 1 | 1 | 1,23 | 2 | 413 | 508,82 |
20250425 | 1 | 1 | 1,21 | 1 | 1 | 1,21 |
20250428 | 1 | 1 | 1,23 | 2 | 249 | 306,27 |
20250429 | 2 | 2 | 2,44 | 1 | 1 | 1,23 |
20250430 | 2 | 1 865 | 2 256,68 | 1 | 1 | 1,24 |
20250501 | 0 | 0 | 0,00 | 0 | 0 | 0,00 |
20250502 | 1 | 1 | 1,22 | 2 | 2 071 | 2 551,46 |
20250505 | 6 | 10 811 | 12 763,44 | 1 | 1 | 1,24 |
20250506 | 3 | 3 021 | 3 629,31 | 2 | 2 | 2,46 |
20250507 | 1 | 1 | 1,23 | 1 | 1 | 1,23 |
20250508 | 1 | 1 | 1,21 | 1 | 1 | 1,21 |
20250509 | 1 | 1 | 1,23 | 1 | 1 | 1,23 |
20250512 | 3 | 2 191 | 2 629,20 | 1 | 1 | 1,20 |
20250513 | 1 | 1 | 1,23 | 2 | 4 | 4,93 |
20250514 | 1 | 1 | 1,23 | 1 | 1 | 1,23 |
20250515 | 1 | 1 | 1,23 | 1 | 1 | 1,23 |
20250516 | 2 | 2 061 | 2 493,83 | 1 | 1 | 1,23 |
20250519 | 1 | 1 | 1,23 | 1 | 1 | 1,23 |
20250520 | 1 | 1 | 1,21 | 4 | 9 071 | 11 364,29 |
20250521 | 1 | 1 | 1,24 | 2 | 2 | 2,49 |
20250522 | 1 | 1 | 1,24 | 3 | 4 371 | 5 455,20 |
20250523 | 1 | 1 | 1,26 | 4 | 8 381 | 10 768,00 |
20250526 | 1 | 1 | 1,30 | 2 | 2 001 | 2 601,30 |
20250527 | 1 | 1 | 1,31 | 4 | 7 871 | 10 396,13 |
20250528 | 1 | 1 | 1,33 | 3 | 3 579 | 4 767,23 |
20250529 | 4 | 6 071 | 7 774,61 | 1 | 1 | 1,29 |
20250530 | 1 | 1 | 1,29 | 1 | 1 | 1,29 |
20250602 | 1 | 1 | 1,30 | 2 | 474 | 619,98 |
20250603 | 1 | 1 | 1,31 | 1 | 1 | 1,31 |
20250604 | 3 | 3 771 | 4 839,51 | 1 | 1 | 1,29 |
20250605 | 1 | 1 | 1,26 | 1 | 1 | 1,26 |
20250606 | 1 | 1 | 1,28 | 1 | 1 | 1,28 |
20250609 | 1 | 1 | 1,28 | 1 | 1 | 1,28 |
20250610 | 1 | 1 | 1,29 | 2 | 1 951 | 2 520,69 |
20250611 | 3 | 3 002 | 3 833,87 | 1 | 1 | 1,30 |
20250612 | 3 | 3 621 | 4 589,10 | 1 | 1 | 1,30 |
20250613 | 3 | 3 511 | 4 400,52 | 1 | 1 | 1,26 |
20250616 | 2 | 300 | 372,00 | 1 | 1 | 1,24 |
20250617 | 1 | 1 | 1,25 | 1 | 1 | 1,25 |
20250618 | 2 | 961 | 1 180,13 | 1 | 1 | 1,25 |
20250619 | 1 | 1 | 1,25 | 1 | 1 | 1,25 |
20250620 | 2 | 2 491 | 3 058,95 | 1 | 1 | 1,23 |
20250623 | 3 | 3 301 | 4 031,62 | 1 | 1 | 1,22 |
20250624 | 1 | 1 | 1,23 | 1 | 1 | 1,23 |
20250625 | 2 | 2 361 | 2 852,09 | 1 | 1 | 1,21 |
20250626 | 1 | 1 | 1,23 | 1 | 1 | 1,23 |
20250627 | 1 | 1 | 1,23 | 1 | 1 | 1,23 |
20250630 | 4 | 4 761 | 5 678,38 | 1 | 1 | 1,20 |
About ABIONYX Pharma
ABIONYX Pharma is a new-generation biotechnology company whose aim is to contribute to healthcare through innovative therapies in indications where there is no effective or existing treatment, even the rarest ones. Thanks to its partners in research, medicine, biopharmaceuticals and shareholding, the company innovates on a daily basis to offer drugs for the treatment of kidney and ophthalmological diseases, or new apoA-1 vectors used for targeted drug delivery.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250703756010/en/
Contacts:
NewCap
Investor Relations
Louis-Victor Delouvrier
abionyx@newcap.eu
+33 (0)1 44 71 98 53
NewCap
Media Relations
Arthur Rouillé
abionyx@newcap.eu
+33 (0)1 44 71 00 15
